![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 122
Zeitschriftenartikel
Scheubeck, Gabriel 
ORCID: https://orcid.org/0009-0004-2546-6154; Hoffmann, Martin; Jurinovic, Vindi; Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Unterhalt, Michael; Schmidt, Christian; Böck, Hans-Peter; Dührsen, Ulrich; Kaesberger, Joachim; Kremers, Stephan; Lindemann, Hans-Walter; Mantovani, Luisa; Hiddemann, Wolfgang; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2024):
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.
In: Annals of Hematology, Bd. 103: S. 2373-2380
[PDF, 1MB]
ORCID: https://orcid.org/0009-0004-2546-6154; Hoffmann, Martin; Jurinovic, Vindi; Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Unterhalt, Michael; Schmidt, Christian; Böck, Hans-Peter; Dührsen, Ulrich; Kaesberger, Joachim; Kremers, Stephan; Lindemann, Hans-Walter; Mantovani, Luisa; Hiddemann, Wolfgang; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2024):
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.
In: Annals of Hematology, Bd. 103: S. 2373-2380
[PDF, 1MB]
Dreyling, Martin; Doorduijn, Jeanette; Giné, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; Gomes da Silva, Maria; Leppä, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron D; Celli, Melania; Hess, Georg; Arcaini, Luca; Visco, Carlo; Meerten, Tom van; Wirths, Stefan; Zinzani, Pier Luigi; Novak, Urban; Herhaus, Peter; Benedetti, Fabio; Sonnevi, Kristina; Hanoun, Christine; Hänel, Matthias; Dierlamm, Judith; Pott, Christiane; Klapper, Wolfram; Gözel, Döndü; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2024):
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 403, Nr. 10441: S. 2293-2306
ORCID: https://orcid.org/0000-0002-0749-1389
(2024):
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 403, Nr. 10441: S. 2293-2306
Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Schmidt, Christian; Stilgenbauer, Stephan ORCID: https://orcid.org/0000-0002-6830-9296; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W.; Feugier, Pierre; Wit, Maike de; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich ORCID: https://orcid.org/0000-0001-6082-7710; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen ORCID: https://orcid.org/0000-0003-1256-173X; Giagounidis, Aristoteles A. N.; Dargel, Beate; Durot, Eric ORCID: https://orcid.org/0000-0003-3463-0089; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver ORCID: https://orcid.org/0000-0002-0987-7373; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Ribrag, Vincent und Dreyling, Martin
(2024):
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network.
In: Leukemia, Bd. 38: S. 1307-1314
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Schmidt, Christian; Stilgenbauer, Stephan ORCID: https://orcid.org/0000-0002-6830-9296; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W.; Feugier, Pierre; Wit, Maike de; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich ORCID: https://orcid.org/0000-0001-6082-7710; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen ORCID: https://orcid.org/0000-0003-1256-173X; Giagounidis, Aristoteles A. N.; Dargel, Beate; Durot, Eric ORCID: https://orcid.org/0000-0003-3463-0089; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver ORCID: https://orcid.org/0000-0002-0987-7373; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Ribrag, Vincent und Dreyling, Martin
(2024):
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network.
In: Leukemia, Bd. 38: S. 1307-1314
[PDF, 1MB]
Khouja, Mouhamad ORCID: https://orcid.org/0000-0002-9892-9461; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Pal, Karol ORCID: https://orcid.org/0000-0002-7726-4691; Stewart, Peter James; Regmi, Binaya ORCID: https://orcid.org/0009-0003-2663-0983; Schwarz, Martin; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Alig, Stefan K. ORCID: https://orcid.org/0000-0001-6825-702X; Darzentas, Nikos; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Gonzalez de Castro, David ORCID: https://orcid.org/0000-0003-0580-5636; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2024):
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials.
In: Leukemia, Bd. 38, Nr. 12: S. 2675-2684
[PDF, 3MB]
ORCID: https://orcid.org/0000-0002-9892-9461; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Pal, Karol ORCID: https://orcid.org/0000-0002-7726-4691; Stewart, Peter James; Regmi, Binaya ORCID: https://orcid.org/0009-0003-2663-0983; Schwarz, Martin; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Alig, Stefan K. ORCID: https://orcid.org/0000-0001-6825-702X; Darzentas, Nikos; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Gonzalez de Castro, David ORCID: https://orcid.org/0000-0003-0580-5636; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2024):
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials.
In: Leukemia, Bd. 38, Nr. 12: S. 2675-2684
[PDF, 3MB]
Koehler, Viktoria Florentine; Knösel, Thomas ORCID: https://orcid.org/0000-0002-1822-0197; Hasmann, Sandra Elisabeth; Scherer, Clemens ORCID: https://orcid.org/0000-0003-2816-6793; Hellmuth, Johannes C. ORCID: https://orcid.org/0000-0001-8409-3037; Muenchhoff, Maximilian ORCID: https://orcid.org/0000-0001-7016-0470; Munker, Stefan Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Ladurner, Roland und Spitzweg, Christine
(2023):
Thyroidal ACE2 protein expression and thyroid function tests in patients with COVID-19. Results from a retrospective case series and a prospective cohort study.
In: Thyroid, Bd. 33, Nr. 2
ORCID: https://orcid.org/0000-0002-1822-0197; Hasmann, Sandra Elisabeth; Scherer, Clemens ORCID: https://orcid.org/0000-0003-2816-6793; Hellmuth, Johannes C. ORCID: https://orcid.org/0000-0001-8409-3037; Muenchhoff, Maximilian ORCID: https://orcid.org/0000-0001-7016-0470; Munker, Stefan Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Ladurner, Roland und Spitzweg, Christine
(2023):
Thyroidal ACE2 protein expression and thyroid function tests in patients with COVID-19. Results from a retrospective case series and a prospective cohort study.
In: Thyroid, Bd. 33, Nr. 2
Stevens, Wendy B. C.; Los-de Vries, G. Tjitske; Langois-Jacques, Carole; Clear, Andrew J.; Stathi, Phylicia; Sander, Birgitta; Rosenwald, Andreas; Calaminici, Maria; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hiddemann, Wolfgang; Gaulard, Philippe; Salles, Gilles; Klapper, Wolfram; Xerri, Luc; Burton, Catherine; Tooze, Reuben M.; Smith, Alexandra G.; Buske, Christian; Scott, David W.; Natkunam, Yasodha; Advani, Ranjana; Sehn, Laurie H.; Raemaekers, John; Gribben, John; Lockmer, Sandra; Kimby, Eva; Kersten, Marie José; Maucort-Boulch, Delphine; Ylstra, Bauke; Dijk, Erik van und Jong, Daphne de
(2023):
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.
In: HemaSphere, Bd. 7, Nr. 4, e863
ORCID: https://orcid.org/0000-0002-0749-1389; Hiddemann, Wolfgang; Gaulard, Philippe; Salles, Gilles; Klapper, Wolfram; Xerri, Luc; Burton, Catherine; Tooze, Reuben M.; Smith, Alexandra G.; Buske, Christian; Scott, David W.; Natkunam, Yasodha; Advani, Ranjana; Sehn, Laurie H.; Raemaekers, John; Gribben, John; Lockmer, Sandra; Kimby, Eva; Kersten, Marie José; Maucort-Boulch, Delphine; Ylstra, Bauke; Dijk, Erik van und Jong, Daphne de
(2023):
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.
In: HemaSphere, Bd. 7, Nr. 4, e863
Bücklein, Veit; Perez, Ariel; Rejeski, Kai; Iacoboni, Gloria; Jurinovic, Vindi; Holtick, Udo; Penack, Olaf; Kharboutli, Soraya; Blumenberg, Viktoria; Ackermann, Josephine; Frölich, Lisa; Johnson, Grace; Patel, Kedar; Arciola, Brian; Mhaskar, Rahul; Wood, Anthony; Schmidt, Christian; Albanyan, Omar; Gödel, Philipp; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Subklewe, Marion und Jain, Michael D.
(2023):
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.
In: HemaSphere, Bd. 7, Nr. 8, e907
ORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Subklewe, Marion und Jain, Michael D.
(2023):
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.
In: HemaSphere, Bd. 7, Nr. 8, e907
Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Bittenbring, Joerg Thomas; Huebel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Juergen; Glass, Bertram; Huettmann, Andreas; Schaefer-Eckart, Kerstin; Silkenstedt, Elisabeth; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis.
In: Annals of Hematology, Bd. 102: S. 2791-2801
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Bittenbring, Joerg Thomas; Huebel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Juergen; Glass, Bertram; Huettmann, Andreas; Schaefer-Eckart, Kerstin; Silkenstedt, Elisabeth; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis.
In: Annals of Hematology, Bd. 102: S. 2791-2801
[PDF, 1MB]
Scheubeck, Gabriel ORCID: https://orcid.org/0009-0004-2546-6154; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Schmidt, Christian; Unterhalt, Michael; Rosenwald, Andreas; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Evangelista, Andrea; Ladetto, Marco; Jerkeman, Mats ORCID: https://orcid.org/0000-0003-4509-6707; Ferrero, Simone ORCID: https://orcid.org/0000-0002-9711-1502; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
In: Leukemia, Bd. 37, Nr. 9: S. 1887-1894
[PDF, 1MB]
ORCID: https://orcid.org/0009-0004-2546-6154; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Schmidt, Christian; Unterhalt, Michael; Rosenwald, Andreas; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Evangelista, Andrea; Ladetto, Marco; Jerkeman, Mats ORCID: https://orcid.org/0000-0003-4509-6707; Ferrero, Simone ORCID: https://orcid.org/0000-0002-9711-1502; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
In: Leukemia, Bd. 37, Nr. 9: S. 1887-1894
[PDF, 1MB]
Blumenberg, Viktoria ORCID: https://orcid.org/0000-0003-1379-0876; Galina, Busch; Baumann, Stephan ORCID: https://orcid.org/0009-0001-2804-2072; Jitschin, Regina; Iacoboni, Gloria ORCID: https://orcid.org/0000-0003-0805-9288; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Gallur, Laura ORCID: https://orcid.org/0000-0001-6293-9281; Iraola-Truchuelo, Josu ORCID: https://orcid.org/0000-0002-9909-3715; Winkelmann, Michael; Hellwig, Konstantin ORCID: https://orcid.org/0000-0001-9001-2176; Schmidt, Christian; Frölich, Lisa; Tast, Benjamin; Hildebrand, Friederike; Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Dekorsy, Franziska J.; Schmidkonz, Christian; Bäuerle, Tobias; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Mougiakakos, Dimitrios ORCID: https://orcid.org/0000-0002-2817-6660; Müller, Fabian ORCID: https://orcid.org/0000-0001-5487-5839; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Mackensen, Andreas ORCID: https://orcid.org/0000-0002-0685-4483; Völkl, Simon und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL.
In: Blood Advances, Bd. 7, Nr. 22: S. 6844-6849
[PDF, 498kB]
ORCID: https://orcid.org/0000-0003-1379-0876; Galina, Busch; Baumann, Stephan ORCID: https://orcid.org/0009-0001-2804-2072; Jitschin, Regina; Iacoboni, Gloria ORCID: https://orcid.org/0000-0003-0805-9288; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Gallur, Laura ORCID: https://orcid.org/0000-0001-6293-9281; Iraola-Truchuelo, Josu ORCID: https://orcid.org/0000-0002-9909-3715; Winkelmann, Michael; Hellwig, Konstantin ORCID: https://orcid.org/0000-0001-9001-2176; Schmidt, Christian; Frölich, Lisa; Tast, Benjamin; Hildebrand, Friederike; Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Dekorsy, Franziska J.; Schmidkonz, Christian; Bäuerle, Tobias; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Mougiakakos, Dimitrios ORCID: https://orcid.org/0000-0002-2817-6660; Müller, Fabian ORCID: https://orcid.org/0000-0001-5487-5839; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Mackensen, Andreas ORCID: https://orcid.org/0000-0002-0685-4483; Völkl, Simon und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL.
In: Blood Advances, Bd. 7, Nr. 22: S. 6844-6849
[PDF, 498kB]
Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Jurinovic, Vindi; Trotman, Judith ORCID: https://orcid.org/0000-0001-8009-4593; Kehden, Britta; Unterhalt, Michael; Herold, Michael ORCID: https://orcid.org/0000-0002-6801-3292; Jagt, Richard van der ORCID: https://orcid.org/0000-0001-5706-0109; Janssens, Ann; Kneba, Michael; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Young, Moya; Schmidt, Christian; Knapp, Andrea; Nielsen, Tina; Brown, Helen ORCID: https://orcid.org/0009-0007-3637-891X; Spielewoy, Nathalie; Harbron, Chris; Bottos, Alessia; Mundt, Kirsten; Marcus, Robert; Hiddemann, Wolfgang und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma. A Prospective Analysis of the Phase III GALLIUM Study.
In: Journal of Clinical Oncology
[PDF, 794kB]
ORCID: https://orcid.org/0009-0005-9260-8340; Jurinovic, Vindi; Trotman, Judith ORCID: https://orcid.org/0000-0001-8009-4593; Kehden, Britta; Unterhalt, Michael; Herold, Michael ORCID: https://orcid.org/0000-0002-6801-3292; Jagt, Richard van der ORCID: https://orcid.org/0000-0001-5706-0109; Janssens, Ann; Kneba, Michael; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Young, Moya; Schmidt, Christian; Knapp, Andrea; Nielsen, Tina; Brown, Helen ORCID: https://orcid.org/0009-0007-3637-891X; Spielewoy, Nathalie; Harbron, Chris; Bottos, Alessia; Mundt, Kirsten; Marcus, Robert; Hiddemann, Wolfgang und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma. A Prospective Analysis of the Phase III GALLIUM Study.
In: Journal of Clinical Oncology
[PDF, 794kB]
Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Delfau-Larue, Marie-Hélène ORCID: https://orcid.org/0000-0002-8010-2343; Macintyre, Elizabeth; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Tilly, Hervé ORCID: https://orcid.org/0000-0001-7022-5246; Wirths, Stefan ORCID: https://orcid.org/0000-0003-2494-9862; Feugier, Pierre; Hübel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C. ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2023):
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma. Results From the European Mantle Cell Lymphoma Elderly Trial.
In: Journal of Clinical Oncology, Bd. 42, Nr. 5: S. 538-549
ORCID: https://orcid.org/0000-0002-0749-1389; Delfau-Larue, Marie-Hélène ORCID: https://orcid.org/0000-0002-8010-2343; Macintyre, Elizabeth; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Tilly, Hervé ORCID: https://orcid.org/0000-0001-7022-5246; Wirths, Stefan ORCID: https://orcid.org/0000-0003-2494-9862; Feugier, Pierre; Hübel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C. ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2023):
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma. Results From the European Mantle Cell Lymphoma Elderly Trial.
In: Journal of Clinical Oncology, Bd. 42, Nr. 5: S. 538-549
Herold, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Janssens, Ann; McCarthy, Helen; Tedeschi, Alessandra; Pocock, Chris; Rosta, Andras; Trněný, Marek; Nielsen, Tina G.; Knapp, Andrea; Hiddemann, Wolfgang und Marcus, Robert
(2022):
Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial.
In: HemaSphere, Bd. 6, Nr. 3, e699
[PDF, 558kB]
ORCID: https://orcid.org/0000-0002-0749-1389; Janssens, Ann; McCarthy, Helen; Tedeschi, Alessandra; Pocock, Chris; Rosta, Andras; Trněný, Marek; Nielsen, Tina G.; Knapp, Andrea; Hiddemann, Wolfgang und Marcus, Robert
(2022):
Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial.
In: HemaSphere, Bd. 6, Nr. 3, e699
[PDF, 558kB]
Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Perez, Ariel; Iacoboni, Gloria; Penack, Olaf; Bücklein, Veit; Jentzsch, Liv; Mougiakakos, Dimitrios; Johnson, Grace; Arciola, Brian; Carpio, Cecilia; Blumenberg, Viktoria; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Locke, Frederick L; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Mackensen, Andreas; Bethge, Wolfgang; Barba, Pere; Jain, Michael D ORCID: https://orcid.org/0000-0002-7789-1257 und Subklewe, Marion
(2022):
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, e004475
[PDF, 5MB]
ORCID: https://orcid.org/0000-0003-3905-0251; Perez, Ariel; Iacoboni, Gloria; Penack, Olaf; Bücklein, Veit; Jentzsch, Liv; Mougiakakos, Dimitrios; Johnson, Grace; Arciola, Brian; Carpio, Cecilia; Blumenberg, Viktoria; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Locke, Frederick L; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Mackensen, Andreas; Bethge, Wolfgang; Barba, Pere; Jain, Michael D ORCID: https://orcid.org/0000-0002-7789-1257 und Subklewe, Marion
(2022):
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, e004475
[PDF, 5MB]
Horn, Heike; Jurinovic, Vindi; Leich, Ellen; Kalmbach, Sabrina; Bausinger, Julia; Staiger, Annette M.; Kurz, Katrin S.; Möller, Peter; Bernd, Heinz-Wolfram; Feller, Alfred C.; Koch, Karoline; Klapper, Wolfram; Stein, Harald; Hansmann, Martin-Leo; Hartmann, Sylvia; Scheubeck, Gabriel; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Hiddemann, Wolfgang; Herfarth, Klaus; Engelhard, Marianne; Rosenwald, Andreas; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Ott, German
(2022):
Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.
In: HemaSphere, Bd. 6, Nr. 9, e767
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-0358-5249; Hiddemann, Wolfgang; Herfarth, Klaus; Engelhard, Marianne; Rosenwald, Andreas; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Ott, German
(2022):
Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.
In: HemaSphere, Bd. 6, Nr. 9, e767
[PDF, 1MB]
Köhler, Viktoria Florentine ORCID: https://orcid.org/0000-0002-2665-1181; Adam, Pia ORCID: https://orcid.org/0000-0003-3862-4639; Fuss, Carmina Teresa; Jiang, Linmiao; Berg, Elke; Frank-Raue, Karin; Raue, Friedhelm; Hoster, Eva; Knösel, Thomas ORCID: https://orcid.org/0000-0002-1822-0197; Schildhaus, Hans-Ulrich ORCID: https://orcid.org/0000-0002-9856-7050; Negele, Thomas; Siebolts, Udo; Lorenz, Kerstin; Allelein, Stephanie; Schott, Matthias; Spitzweg, Christine und Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161
(2022):
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors — A Retrospective Multi-Center Registry Analysis.
In: Cancers, Bd. 14, Nr. 14, 3405
[PDF, 413kB]
ORCID: https://orcid.org/0000-0002-2665-1181; Adam, Pia ORCID: https://orcid.org/0000-0003-3862-4639; Fuss, Carmina Teresa; Jiang, Linmiao; Berg, Elke; Frank-Raue, Karin; Raue, Friedhelm; Hoster, Eva; Knösel, Thomas ORCID: https://orcid.org/0000-0002-1822-0197; Schildhaus, Hans-Ulrich ORCID: https://orcid.org/0000-0002-9856-7050; Negele, Thomas; Siebolts, Udo; Lorenz, Kerstin; Allelein, Stephanie; Schott, Matthias; Spitzweg, Christine und Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161
(2022):
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors — A Retrospective Multi-Center Registry Analysis.
In: Cancers, Bd. 14, Nr. 14, 3405
[PDF, 413kB]
Hermine, Olivier ORCID: https://orcid.org/0000-0003-2574-3874; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Walewski, Jan ORCID: https://orcid.org/0000-0003-4247-2674; Bosly, André; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Szymczyk, Michal; Pott, Christiane; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Metzner, Bernd; Sibon, David ORCID: https://orcid.org/0000-0002-9205-625X; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2022):
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma. Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 41, Nr. 3: S. 479-484
ORCID: https://orcid.org/0000-0003-2574-3874; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Walewski, Jan ORCID: https://orcid.org/0000-0003-4247-2674; Bosly, André; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Szymczyk, Michal; Pott, Christiane; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Metzner, Bernd; Sibon, David ORCID: https://orcid.org/0000-0002-9205-625X; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2022):
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma. Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 41, Nr. 3: S. 479-484
Casulo, Carla ORCID: https://orcid.org/0000-0003-4998-9932; Dixon, Jesse G.; Le-Rademacher, Jennifer ORCID: https://orcid.org/0000-0002-2234-7430; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hochster, Howard S. ORCID: https://orcid.org/0000-0002-9893-1529; Hiddemann, Wolfgang; Marcus, Robert; Kimby, Eva; Herold, Michael; Sebban, Catherine; Gyan, Emmanuel ORCID: https://orcid.org/0000-0002-7651-9189; Foon, Kenneth; Nielsen, Tina; Vitolo, Umberto ORCID: https://orcid.org/0000-0001-7772-2747; Salles, Gilles A. ORCID: https://orcid.org/0000-0002-9541-8666; Shi, Qian und Flowers, Christopher R.
(2022):
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
In: Blood, Bd. 139, Nr. 11: S. 1684-1693
ORCID: https://orcid.org/0000-0003-4998-9932; Dixon, Jesse G.; Le-Rademacher, Jennifer ORCID: https://orcid.org/0000-0002-2234-7430; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hochster, Howard S. ORCID: https://orcid.org/0000-0002-9893-1529; Hiddemann, Wolfgang; Marcus, Robert; Kimby, Eva; Herold, Michael; Sebban, Catherine; Gyan, Emmanuel ORCID: https://orcid.org/0000-0002-7651-9189; Foon, Kenneth; Nielsen, Tina; Vitolo, Umberto ORCID: https://orcid.org/0000-0001-7772-2747; Salles, Gilles A. ORCID: https://orcid.org/0000-0002-9541-8666; Shi, Qian und Flowers, Christopher R.
(2022):
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
In: Blood, Bd. 139, Nr. 11: S. 1684-1693
Villa, Diego; Hoster, Eva; Hermine, Olivier; Klapper, Wolfram; Szymczyk, Michal; Bosly, Andre; Unterhalt, Michael; Rimsza, Lisa M.; Ramsower, Colleen A.; Freeman, Ciara L.; Scott, David W.; Gerrie, Alina S.; Savage, Kerry J.; Sehn, Laurie H. und Dreyling, Martin
(2022):
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.
In: Blood Advances, Bd. 6, Nr. 18: S. 5285-5294
Los-deVries, G. Tjitske; Stevens, Wendy B. C.; Dijk, Erik van; Langois-Jacques, Carole; Clear, Andrew J.; Stathi, Phylicia; Roemer, Margaretha G. M.; Mendeville, Matias; Hijmering, Nathalie J.; Sander, Birgitta; Rosenwald, Andreas; Calaminici, Maria; Hoster, Eva; Hiddemann, Wolfgang; Gaulard, Philippe; Salles, Gilles; Horn, Heike; Klapper, Wolfram; Xerri, Luc; Burton, Catherine; Tooze, Reuben M.; Smith, Alexandra G.; Buske, Christian; Scott, David W.; Natkunam, Yasodha; Advani, Ranjana; Sehn, Laurie H.; Raemaekers, John; Gribben, John; Kimby, Eva; Kersten, Marie Jose; Maucort-Boulch, Delphine; Ylstra, Bauke und Jong, Daphne de
(2022):
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.
In: Blood Advances, Bd. 6, Nr. 18: S. 5482-5493
Adolf, Christian; Görge, Veronika; Sturm, Lisa; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Reincke, Martin; Heinrich, Daniel A.; Hoster, Eva; Schneider, Holger und Handgrif, Laura
(2021):
Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism: A Prospective Cohort Study.
In: Hypertension, Bd. 77, Nr. 4: S. 1332-1340
ORCID: https://orcid.org/0000-0001-7826-3984; Reincke, Martin; Heinrich, Daniel A.; Hoster, Eva; Schneider, Holger und Handgrif, Laura
(2021):
Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism: A Prospective Cohort Study.
In: Hypertension, Bd. 77, Nr. 4: S. 1332-1340
Aukema, Sietse M.; Croci, Giorgio A.; Bens, Susanne; Oehl-Huber, Kathrin; Wagener, Rabea; Ott, German; Rosenwald, Andreas; Kluin, Philip M.; Berg, Eva van den; Kreuz, Markus; Bausinger, Julia; Belder, Wilfried; Oschlies, Ilske; Dyer, Martin J. S.; Jayne, Sandrine; Siebert, Reiner; Klapper, Wolfram und Hoster, Eva
(2021):
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
In: Virchows Archiv
Thurner, Lorenz; Fadle, Natalie; Bittenbring, Jörg Thomas; Regitz, Evi; Schuck, Rita; Cetin, Onur; Stuhr, Arianne; Rixecker, Torben; Murawski, Niels M.; Poeschel, Viola; Kaddu-Mulindwa, Dominic; Preuss, Klaus Dieter; Stilgenbauer, Stephan; Hermine, Olivier; Kluin-Nelemans, Jc C.; Hartmann, Sylvia; Dreyling, Martin; Pott, Christiane; Bewarder, Moritz und Hoster, Eva
(2021):
LRPAP1-autoantibodies in mantle cell lymphoma are associated with superior outcome.
In: Blood, Bd. 137, Nr. 23: S. 3251-3258
Hirt, Carsten; Hoster, Eva; Unterhalt, Michael; Hänel, Mathias; Prange-Krex, Gabriele; Forstpointner, Roswitha; Florschütz, Axel; Graeven, Ullrich; Frickhofen, Norbert; Wulf, Gerald; Lengfelder, Eva; Lerchenmüller, Christian; Schlag, Rudolf; Dierlamm, Judith; Fischer von Weikersthal, Ludwig; Ahmed, Asima; Harich, Hanns-Detlev; Rosenwald, Andreas; Klapper, Wolfram; Dreyling, Martin; Hiddemann, Wolfgang und Herold, Michael
(2021):
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients. A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
In: HemaSphere, Bd. 5, Nr. 7, e600
Eder, Katharina; Polterauer, Daniel; Semmelbauer, Sebastian; Schuster, Maria; Rader, Tobias; Hoster, Eva und Flatz, Wilhelm
(2021):
Comparison of ABR and ASSR using narrow-band-chirp-stimuli in children with cochlear malformation and/or cochlear nerve hypoplasia suffering from severe/profound hearing loss.
In: European Archives of Oto-Rhino-Laryngology
[PDF, 997kB]
Koehler, Viktoria Florentine; Berg, Elke; Adam, Pia; Weber, Gian-Luca; Pfestroff, Andreas; Luster, Markus; Kutsch, Jana Maria; Lapa, Constantin; Sandner, Benjamin; Rayes, Nada; Fuss, Carmina Teresa; Kreissl, Michael; Hoster, Eva; Allelein, Stephanie; Schott, Matthias; Todica, Andrei; Fassnacht, Martin; Kroiss, Matthias und Spitzweg, Christine
(2021):
Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer.
In: Thyroid
Zoellner, Anna-Katharina; Unterhalt, Michael; Stilgenbauer, Stephan; Hübel, Kai; Klapper, Wolfram; Hiddemann, Wolfgang; Dreyling, Martin und Hoster, Eva
(2021):
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial.
In: The Lancet. Haematology, Bd. 8, Nr. 9, e648-e657
Koehler, Viktoria F.; Fuss, Carmina T.; Berr, Christina M.; Frank-Raue, Karin; Raue, Friedhelm; Hoster, Eva; Hepprich, Matthias; Christ, Emanuel; Pusl, Thomas; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Spitzweg, Christine und Kroiss, Matthias
(2021):
Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.
In: Clinical Endocrinology
[PDF, 550kB]
ORCID: https://orcid.org/0000-0002-9817-9875; Spitzweg, Christine und Kroiss, Matthias
(2021):
Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.
In: Clinical Endocrinology
[PDF, 550kB]
Zaccaria, Gian Maria; Ferrero, Simone; Hoster, Eva; Passera, Roberto; Evangelista, Andrea; Genuardi, Elisa; Drandi, Daniela; Ghislieri, Marco; Barbero, Daniela; Del Giudice, Monica and Moia; Merli, Francesco; Vallisa, Daniele; Spina, Michele; Pascarella, Anna; Latte, Giancarlo; Patti, Caterina; Fabbri, Alberto; Guarini, Attilio; Vitolo, Umberto; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Cortelazzo, Sergio; Dreyling, Martin und Ladetto, Marco
(2021):
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial.
In: Cancers, Bd. 14, Nr. 1
[PDF, 2MB]
Eder, Katharina; Polterauer, Daniel; Semmelbauer, Sebastian; Schuster, Maria; Rader, Tobias; Hoster, Eva und Flatz, Wilhelm
(2021):
Comparison of ABR and ASSR using narrow-band-chirp-stimuli in children with cochlear malformation and/or cochlear nerve hypoplasia suffering from severe/profound hearing loss.
In: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, Bd. 279: S. 2845-2855
[PDF, 974kB]
Moertl, Bernhard ORCID: https://orcid.org/0000-0002-8643-4170; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Schmidt, Christian; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Schoel, Wolfgang; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X und Berger, Karin
(2021):
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.
In: Clinical Lymphoma Myeloma and Leukemia
ORCID: https://orcid.org/0000-0002-8643-4170; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Schmidt, Christian; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Schoel, Wolfgang; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X und Berger, Karin
(2021):
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.
In: Clinical Lymphoma Myeloma and Leukemia
Adolf, Christian; Görge, Veronika; Heinrich, Daniel A.; Hoster, Eva; Schneider, Holger; Handgriff, Laura; Künzel, Heike; Sturm, Lisa; Beuschlein, Felix und Reincke, Martin
(2021):
Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism A Prospective Cohort Study.
In: Hypertension, Bd. 77, Nr. 4: S. 1332-1340
Aukema, Sietse M.; Croci, Giorgio A.; Bens, Susanne; Oehl-Huber, Kathrin; Wagener, Rabea; Ott, German; Rosenwald, Andreas; Kluin, Philip M.; Berg, Eva van den; Bosga-Bouwer, Anneke G.; Hoogendoorn, Mels; Hoster, Eva; Bittmann, Iris; Nagel, Inga; Penas, Eva M. Murga; Kreuz, Markus; Bausinger, Julia; Belder, Wilfried; Oschlies, Ilske; Dyer, Martin J. S.; Jayne, Sandrine; Siebert, Reiner und Klapper, Wolfram
(2021):
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
In: Virchows Archiv, Bd. 479, Nr. 1: S. 133-145
Casulo, Carla; Dixon, Jesse G.; Ou, Fang-Shu; Hoster, Eva; Peterson, Bruce A.; Hochster, Howard S.; Brice, Pauline; Ladetto, Marco; Hiddemann, Wolfgang; Marcus, Robert; Kimby, Eva; Herold, Michael; Nielsen, Tina; Morschhauser, Franck; Rummel, Mathias; Hagenbeek, Anton; Vitolo, Umberto; Salles, Gilles A.; Shi, Qian und Flowers, Christopher R.
(2021):
Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials.
In: Blood Advances, Bd. 5, Nr. 6: S. 1737-1745
Eder, Katharina; Polterauer, Daniel; Semmelbauer, Sebastian; Schuster, Maria; Rader, Tobias; Hoster, Eva und Flatz, Wilhelm
(2021):
Comparison of ABR and ASSR using narrow-band-chirp-stimuli in children with cochlear malformation and/or cochlear nerve hypoplasia suffering from severe/profound hearing loss.
In: European Archives of Oto-Rhino-Laryngology, Bd. 279, Nr. 6: S. 2845-2855
Hirt, Carsten; Hoster, Eva; Unterhalt, Michael; Haenel, Mathias; Prange-Krex, Gabriele; Forstpointner, Roswitha; Florschuetz, Axel; Graeven, Ullrich; Frickhofen, Norbert; Wulf, Gerald; Lengfelder, Eva; Lerchenmueller, Christian; Schlag, Rudolf; Dierlamm, Judith; Fischer von Weikersthal, Ludwig; Ahmed, Asima; Harich, Hanns-Detlev; Rosenwald, Andreas; Klapper, Wolfram; Dreyling, Martin; Hiddemann, Wolfgang und Herold, Michael
(2021):
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hamatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
In: Hemasphere, Bd. 5, Nr. 7, e600
Koehler, Viktoria F.; Fuss, Carmina T.; Berr, Christina M.; Frank-Raue, Karin; Raue, Friedhelm; Hoster, Eva; Hepprich, Matthias; Christ, Emanuel; Pusl, Thomas; Reincke, Martin; Spitzweg, Christine und Kroiss, Matthias
(2021):
Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.
In: Clinical Endocrinology, Bd. 96, Nr. 6: S. 847-856
Koehler, Viktoria Florentine; Berg, Elke; Adam, Pia; Weber, Gian-Luca; Pfestroff, Andreas; Luster, Markus; Kutsch, Jana Maria; Lapa, Constantin; Sandner, Benjamin; Rayes, Nada; Fuss, Carmina Teresa; Kreissl, Michael C.; Hoster, Eva; Allelein, Stephanie; Schott, Matthias; Todica, Andrei; Fassnacht, Martin; Kroiss, Matthias und Spitzweg, Christine
(2021):
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer.
In: Thyroid, Bd. 31, Nr. 10: S. 1531-1541
Thurner, Lorenz; Fadle, Natalie; Bittenbring, Joerg Thomas; Regitz, Evi; Schuck, Rita; Cetin, Onur; Stuhr, Ariane; Rixecker, Torben; Murawski, Niels; Poeschel, Viola; Kaddu-Mulindwa, Dominic; Preuss, Klaus-Dieter; Stilgenbauer, Stephan; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Hartmann, Sylvia; Dreyling, Martin; Pott, Christiane; Bewarder, Moritz und Hoster, Eva
(2021):
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.
In: Blood, Bd. 137, Nr. 23: S. 3251-3258
Zoellner, Anna-Katharina; Unterhalt, Michael; Stilgenbauer, Stephan; Huebel, Kai; Thieblemont, Catherine; Metzner, Bernd; Topp, Max; Truemper, Lorenz; Schmidt, Christian; Bouabdallah, Kamal; Krauter, Jürgen; Lenz, Georg; Duerig, Jan; Vergote, Vibeke; Schaefer-Eckart, Kerstin; Andre, Marc; Kluin-Nelemans, Hanneke C.; Hoof, Achiel van; Klapper, Wolfram; Hiddemann, Wolfgang; Dreyling, Martin und Hoster, Eva
(2021):
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label multicentre, randomised, phase 3 trial.
In: Lancet Haematology, Bd. 8, Nr. 9, E648-E657
Alig, Stefan; Jurinovic, Vindi; Esfahani, Mohammad Shahrokh; Haebe, Sarah; Passerini, Verena; Hellmuth, Johannes C.; Gaitzsch, Erik; Keay, William; Tahiri, Natyra; Zoellner, Anna-Katharina; Rosenwald, Andreas; Klapper, Wolfram; Stein, Harald; Feller, Alfred C.; Ott, German; Staiger, Annette M.; Horn, Heike; Hansmann, Martin-Leo; Pott, Christiane; Unterhalt, Michael; Schmidt, Christian; Dreyling, Martin; Alizadeh, Ash A.; Hiddemann, Wolfgang; Hoster, Eva und Weigert, Oliver
(22. September 2020):
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.
In: Blood Advances, Bd. 4, Nr. 18: S. 4451-4462
Pott, Christiane; Sehn, Laurie H.; Belada, David; Gribben, John; Hoster, Eva; Kahl, Brad; Kehden, Britta; Nicolas-Virelizier, Emmanuelle; Spielewoy, Nathalie; Fingerle-Rowson, Guenter; Harbron, Chris; Mundt, Kirsten; Wassner-Fritsch, Elisabeth und Cheson, Bruce D.
(Februar 2020):
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial.
In: Leukemia, Bd. 34, Nr. 2: S. 522-32
Eder, Katharina; Schuster, Maria Elke; Polterauer, Daniel; Neuling, Maike; Hoster, Eva; Hempel, John-Martin und Semmelbauer, Sebastian
(2020):
Comparison of ABR and ASSR using NB-chirp-stimuli in children with severe and profound hearing loss.
In: International Journal of Pediatric Otorhinolaryngology, Bd. 131, 109864
Kluin-Nelemans, Hanneke C.; Hoster, Eva; Hermine, Olivier; Walewski, Jan; Geisler, Christian H.; Trneny, Marek; Stilgenbauer, Stephan; Kaiser, Florian; Doorduijn, Jeanette K.; Salles, Gilles; Szymczyk, Michal; Tilly, Herve; Ribrag, Vincent; Klapper, Wolfram; Pott, Christiane; Unterhalt, Michael; Dreyling, Martin; Kanz, Lothar; Schmidt, Christian; Feugier, Pierre; Thieblemont, Catherine und Zijlstra, Josee M.
(2020):
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial.
In: Journal of Clinical Oncology, Bd. 38, Nr. 3: S. 248-256
Rubinstein, German; Osswald, Andrea; Hoster, Eva; Losa, Marco; Elenkova, Atanaska; Zacharieva, Sabina; Machado, Márcio Carlos; Schopohl, Jochen; Beuschlein, Felix; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Hanzu, Felicia Alexandra; Zopp, Stephanie; Ritzel, Katrin; Riester, Anna; Braun, Leah T.; Kreitschmann-Andermahr, Ilonka; Storr, Helen L.; Bansal, Prachi; Barahona, María-José; Cosaro, Elisa; Dogansen, Sema Ciftci; Johnston, Philip C.; Santos de Oliveira, Ricardo; Raftopoulos, Christian; Scaroni, Carla; Valassi, Elena und Werff, Steven J. A. van der
(2020):
Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients.
In: The Journal of clinical endocrinology and metabolism, Bd. 105, Nr. 3
ORCID: https://orcid.org/0000-0002-9817-9875; Hanzu, Felicia Alexandra; Zopp, Stephanie; Ritzel, Katrin; Riester, Anna; Braun, Leah T.; Kreitschmann-Andermahr, Ilonka; Storr, Helen L.; Bansal, Prachi; Barahona, María-José; Cosaro, Elisa; Dogansen, Sema Ciftci; Johnston, Philip C.; Santos de Oliveira, Ricardo; Raftopoulos, Christian; Scaroni, Carla; Valassi, Elena und Werff, Steven J. A. van der
(2020):
Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients.
In: The Journal of clinical endocrinology and metabolism, Bd. 105, Nr. 3
Staiger, Annette M.; Hoster, Eva; Jurinovic, Vindi; Winter, Stefan; Leich, Ellen; Kalla, Claudia; Möller, Peter; Bernd, Heinz-Wolfram; Feller, Alfred C.; Koch, Karoline; Klapper, Wolfram; Stein, Harald; Hansmann, Martin-Leo; Hartmann, Sylvia; Dreyling, Martin; Weigert, Oliver; Hiddemann, Wolfgang; Herfarth, Klaus; Rosenwald, Andreas; Engelhard, Marianne; Ott, German und Horn, Heike
(2020):
Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles.
In: Blood, Bd. 135, Nr. 3: S. 181-190
Croci, Giorgio A.; Hoster, Eva; Beà, Sílvia; Veloza, Luis; Campo, Elias; Clasen-Linde, Erik; Goswami, Rashmi S.; Helgeland, Lars; Pileri, Stefano; Rymkiewicz, Grzegorz; Reinke, Sarah; Dreyling, Martin; Klapper, Wolfram; Clot, Guillem; Enjuanes, Anna; Scott, David W. und Cabeçadas, José
(2020):
Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11.
In: Virchows Archiv: an international journal of pathology, Bd. 477, Nr. 2: S. 259-267
Roider, Tobias; Wang, Xi; Hüttl, Katrin; Dreger, Peter; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Grabe, Niels; Dreyling, Martin; Pott, Christiane; Ott, German; Hoster, Eva und Dietrich, Sascha
(2020):
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
In: International Journal of Cancer
Koehler, Viktoria F.; Adam, Pia; Frank-Raue, Karin; Raue, Friedhelm; Berg, Elke; Hoster, Eva; Allelein, Stephanie; Schott, Matthias; Kroiss, Matthias und Spitzweg, Christine
(2020):
Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer.
In: Thyroid, Bd. 31, Nr. 3: S. 459-469
Hoffmann, Lea; Feraric, Matthias; Hoster, Eva; Litzenburger, Friederike und Kunzelmann, Karl-Heinz
(2020):
Investigations of the optical properties of enamel and dentin for early caries detection.
In: Clinical Oral Investigations, Bd. 25: S. 1281-1289
Visco, Carlo; Tisi, Maria C.; Evangelista, Andrea; Rocco, Alice di; Arcari, Annalisa; Marino, Dario; Merli, Michele; Piazza, Francesco; Gentile, Massimo; Pelosini, Matteo; Loseto, Giacomo; Hermine, Olivier; Dreyling, Martin; Ruggeri, Marco; Martelli, Maurizio; Hoster, Eva; Vitolo, Umberto und Zöllner, Anna‐Katharina
(Juni 2019):
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
In: British Journal of Haematology, Bd. 185, Nr. 5
Rauert-Wunderlich, Hilka; Mottok, Anja; Scott, David W.; Rimsza, Lisa M.; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Hartmann, Sylvia; Thorns, Christoph; Rymkiewicz, Grzegorz; Holte, Harald; Dreyling, Martin; Hoster, Eva und Rosenwald, Andreas
(Februar 2019):
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
In: British Journal of Haematology, Bd. 184, Nr. 4
Alig, Stefan; Jurinovic, Vindi; Pastore, Alessandro; Haebe, Sarah; Schmidt, Christian; Zoellner, Anna-Katharina; Dreyling, Martin; Unterhalt, Michael; Hoster, Eva; Hiddemann, Wolfgang und Weigert, Oliver
(2019):
Impact of age on clinical risk scores in follicular lymphoma.
In: Blood Advances, Bd. 3, Nr. 7: S. 1033-1038
Rosenwald, Andreas; Bens, Susanne; Advani, Ranjana; Barrans, Sharon; Copie-Bergman, Christiane; Elsensohn, Mad-Helenie; Natkunam, Yaso; Calaminici, Maria; Sander, Birgitta; Baia, Maryse; Smith, Alexandra; Painter, Daniel; Pham, Luu; Zhao, Shuchun; Ziepert, Marita; Jordanova, Ekaterina S.; Molina, Thierry J.; Kersten, Marie José; Kimby, Eva; Klapper, Wolfram; Raemaekers, John; Schmitz, Norbert; Jardin, Fabrice; Stevens, Wendy B. C.; Hoster, Eva; Hagenbeek, Anton; Gribben, John G.; Siebert, Reiner; Gascoyne, Randy D.; Scott, David W.; Gaulard, Philippe; Salles, Gilles; Burton, Catherine; Jong, Daphne de; Sehn, Laurie H. und Maucort-Boulch, Delphine
(2019):
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
In: Journal of Clinical Oncology, Bd. 37, Nr. 35: S. 3359-3368
Mottok, Anja; Jurinovic, Vindi; Farinha, Pedro; Rosenwald, Andreas; Leich, Ellen; Ott, German; Horn, Heike; Klapper, Wolfram; Boesl, Michael; Hiddemann, Wolfgang; Steidl, Christian; Connors, Joseph M.; Sehn, Laurie H.; Gascoyne, Randy D.; Hoster, Eva; Weigert, Oliver und Kridel, Robert
(Januar 2018):
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab-containing regimens.
In: Blood, Bd. 131, Nr. 2: S. 226-235
Aukema, Sietse M.; Hoster, Eva; Rosenwald, Andreas; Canoni, Danielle; Delfau-Larue, Marie-Hélène; Rymkiewicz, Grzegorz; Thorns, Christoph; Hartmann, Sylvia; Kluin-Nelemans, Hanneke; Hermine, Olivier; Dreyling, Martin und Klapper, Wolfram
(Januar 2018):
Expression of TP53 is associated with outcome of MCL independent of MIPI and Ki-67 in trials of the European-MCL Network.
In: Blood, Bd. 131, Nr. 4: S. 417-20
Alig, Stefan; Jurinovic, Vindi; Pastore, Alessandro; Bararia, Deepak; Häbe, Sarah; Hellmuth, Johannes C.; Kridel, Robert; Gascoyne, Randy; Schmidt, Christian; Zöllner, Anna; Buske, Christian; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang; Hoster, Eva und Weigert, Oliver
(2018):
Impact of age on genetics and treatment efficacy in follicular lymphoma.
In: Haematologica
Jurinovic, Vindi; Metzner, Bernd; Pfreundschuh, Michael; Schmitz, Norbert; Wandt, Hannes; Keller, Ulrich; Dreger, Peter; Dreyling, Martin; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva und Weigert, Oliver
(2018):
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
In: Biology of Blood and Marrow Transplantation
Hoster, Eva
(2018):
The FLIPI nowadays: Validation and modification.
In: Blood, Bd. 132, Nr. 1: S. 3-4
Konstandin, Nikola P.; Pastore, Friederike; Herold, Tobias; Dufour, Annika; Rothenberg-Thurley, Maja; Hinrichsen, Tanja; Ksienzyk, Bianka; Tschuri, Sebastian; Schneider, Stephanie; Hoster, Eva; Berdel, Wolfgang E.; Wörmann, Bernhard J.; Sauerland, Maria C.; Braess, Jan; Bohlander, Stefan K.; Klein, Hanns-Georg; Hiddemann, Wolfgang; Metzeler, Klaus H. und Spiekermann, Karsten
(2018):
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA.
In: Blood Advances, Bd. 2, Nr. 20: S. 2724-2731
Shi, Qian; Flowers, Christopher R.; Hiddemann, Wolfgang; Marcus, Robert; Herold, Michael; Hagenbeek, Anton; Kimby, Eva; Hochster, Howard; Vitolo, Umberto; Peterson, Bruce A.; Gyan, Emmanuel; Ghielmini, Michele; Nielsen, Tina; Bedout, Sabine de; Fu, Tommy; Valente, Nancy; Fowler, Nathan H.; Hoster, Eva; Ladetto, Marco; Morschhauser, Franck; Zucca, Emanuele; Salles, Gilles und Sargent, Daniel J.
(10. Februar 2017):
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.
In: Journal of clinical oncology, Bd. 35, Nr. 5: S. 552-560
Clauss, Sebastian; Scherr, Johannes; Hanley, Alan; Schneider, Jens; Klier, Ina; Lackermair, Korbinian; Hoster, Eva; Vogeser, Michael; Nieman, David C.; Halle, Martin und Nickel, Thomas
(16. Januar 2017):
Impact of polyphenols on physiological stress and cardiac burden in marathon runners - results from a substudy of the BeMaGIC study.
In: Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, Bd. 42, Nr. 5: S. 523-528
Dai, Beiying; Grau, Michael; Juilland, Mélanie; Klener, Pavel; Höring, Elisabeth; Molinsky, Jan; Schimmack, Gisela; Aukema, Sietse M.; Hoster, Eva; Vogt, Niklas; Staiger, Annette M.; Erdmann, Tabea; Xu, Wendan; Erdmann, Kristian; Dzyuba, Nicole; Madle, Hannelore; Berdel, Wolfgang E.; Trneny, Marek; Dreyling, Martin; Jöhrens, Korinna; Lenz, Peter; Rosenwald, Andreas; Siebert, Reiner; Tzankov, Alexandar; Klapper, Wolfram; Anagnostopoulos, Ioannis; Krappmann, Daniel; Ott, German; Thome, Margot und Lenz, Georg
(2017):
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.
In: Blood, Bd. 129, Nr. 3: S. 333-346
Stevens, Wendy B. C.; Mendeville, Matias; Redd, Robert; Clear, Andrew J.; Bladergroen, Reno; Calaminici, Maria; Rosenwald, Andreas; Hoster, Eva; Hiddemann, Wolfgang; Gaulard, Philippe; Xerri, Luc; Salles, Gilles; Klapper, Wolfram; Pfreundschuh, Michael; Jack, Andrew; Gascoyne, Randy D.; Natkunam, Yasodha; Advani, Ranjana; Kimby, Eva; Sander, Birgitta; Sehn, Laurie H.; Hagenbeek, Anton; Raemaekers, John; Gribben, John; Kersten, Marie José; Ylstra, Bauke; Weller, Edie und Jong, Daphne de
(2017):
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.
In: Haematologica, Bd. 102, Nr. 8: S. 1413-1423
Lackermair, Korbinian; Scherr, Johannes; Waidhauser, Georg; Methe, Heiko; Hoster, Eva; Nieman, David C.; Hanley, Alan; Clauss, Sebastian; Halle, Martin und Nickel, Thomas
(2017):
Influence of polyphenol-rich diet on exercise-induced immunomodulation in male endurance athletes.
In: Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme: S. 1-8
Ruff, Suzan; Bocklet, Tobias; Nöth, Elmar; Müller, Joachim; Hoster, Eva und Schuster, Maria
(2017):
Speech Production Quality of Cochlear Implant Users with Respect to Duration and Onset of Hearing Loss.
In: ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery, Bd. 79, Nr. 5: S. 282-294
Leich, E.; Hoster, Eva; Wartenberg, M.; Unterhalt, Michael; Siebert, R.; Koch, K.; Klapper, Wolfram; Engelhard, Marianne; Puppe, B.; Horn, Heike; Staiger, A. M.; Stuhlmann-Laeisz, C.; Bernd, Heinz Wolfram; Feller, A. C.; Hummel, Martina; Lenze, D.; Stein, H.; Hartmann, S.; Hansmann, Martin-Leo; Möller, P.; Hiddemann, Wolfgang; Dreyling, Martin; Ott, German und Rosenwald, Andreas
(2016):
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.
In: Leukemia, Bd. 30, Nr. 4: S. 854-860
Clauss, S.; Wakili, R.; Hildebrand, B.; Kääb, S.; Hoster, Eva; Klier, I.; Martens, E.; Hanley, A.; Hanssen, H.; Halle, M. und Nickel, T.
(2016):
MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study - A Sub-Study of the Munich Marathon Study).
In: PLOS ONE 11(2), e0148599 [PDF, 3MB]
In: PLOS ONE 11(2), e0148599 [PDF, 3MB]
Dreyling, Martin; Schnaiter, A.; Schmidt, C. und Hoster, Eva
(2016):
Aktuelle Therapiestrategien beim Mantelzelllymphom.
In: Internist (Berl), Bd. 57, Nr. 3: S. 230-237
Hoster, Eva; Rosenwald, Andreas; Berger, F.; Bernd, Heinz Wolfram; Hartmann, S.; Loddenkemper, Christoph; Barth, Thomas E. F.; Brousse, N.; Pileri, S.; Rymkiewicz, G.; Kodet, Roman; Stilgenbauer, S.; Forstpointner, R.; Thieblemont, C.; Hallek, M.; Coiffier, B.; Vehling-Kaiser, U.; Bouabdallah, R.; Kanz, L.; Pfreundschuh, M.; Schmidt, C.; Ribrag, Vincent; Hiddemann, Wolfgang; Unterhalt, Michael; Kluin-Nelemans, J. C.; Hermine, Olivier; Dreyling, Martin und Klapper, Wolfram
(2016):
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 34, Nr. 12: S. 1386-1394
Hiddemann, Wolfgang; Hoster, Eva; Schmidt, C.; Dreyling, Martin und Unterhalt, Michael
(2016):
Aktuelle Therapiestrategien beim follikulären Lymphom.
In: Internist, Bd. 57, Nr. 3: S. 222-229
Koch, K.; Hoster, Eva; Ziepert, M.; Unterhalt, Michael; Ott, German; Rosenwald, Andreas; Hansmann, Martin-Leo; Bernd, W.; Stein, H.; Pöschel, V.; Dreyling, Martin; Trümper, L.; Löffler, M.; Schmitz, N.; Hiddemann, Wolfgang; Pfreundschuh, M. und Klapper, Wolfram
(2016):
Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL.
In: Annals of Oncology, Bd. 27, Nr. 7: S. 1323-1329
Klapper, Wolfram; Koch, K.; Hoster, Eva; Schmitz, N. und Hiddemann, Wolfgang
(2016):
Reply to the letter to the editor ’the clinical dilemma of grade 3 follicular lymphoma’ by Sorigue et al.
In: Annals of Oncology, Bd. 27, Nr. 12: S. 2303-2304
Hermine, Olivier; Hoster, Eva; Walewski, J.; Bosly, A.; Stilgenbauer, S.; Thieblemont, C.; Szymczyk, Michal; Bouabdallah, R.; Kneba, M.; Hallek, M.; Salles, G.; Feugier, P.; Ribrag, Vincent; Birkmann, J.; Forstpointner, R.; Haioun, C.; Hänel, M.; Casasnovas, R. O.; Finke, J.; Peter, N.; Bouabdallah, K.; Sebban, C.; Fischer, T.; Dührsen, U.; Metzner, B.; Maschmeyer, G.; Kanz, L.; Schmidt, C.; Delarue, R.; Brousse, N.; Klapper, Wolfram; Macintyre, E.; Delfau-Larue, M. H.; Pott, Christiane; Hiddemann, Wolfgang; Unterhalt, Michael und Dreyling, Martin
(2016):
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 388, Nr. 10044: S. 565-575
Hoster, Eva und Pott, Christiane
(2016):
Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment.
In: Hematology. American Society of Hematology. Education Program, Bd. 2016, Nr. 1: S. 437-445
Pastore, A.; Jurinovic, Vindi; Kridel, R.; Hoster, Eva; Staiger, A. M.; Szczepanowski, M.; Pott, Christiane; Kopp, N.; Murakami, M.; Horn, Heike; Leich, E.; Moccia, A. A.; Mottok, A.; Sunkavalli, A.; van Hummelen, P.; Ducar, M.; Ennishi, D.; Shulha, H. P.; Hother, C.; Connors, J. M.; Sehn, L. H.; Dreyling, Martin; Neuberg, D.; Moller, P.; Feller, A. C.; Hansmann, Martin-Leo; Stein, H.; Rosenwald, Andreas; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Hiddemann, Wolfgang; Gascoyne, R. D.; Weinstock, D. M. und Weigert, O.
(2015):
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
In: Lancet Oncology, Bd. 16, Nr. 9: S. 1111-1122
Rudelius, M.; Rauert-Wunderlich, H.; Hartmann, Elena; Hoster, Eva; Dreyling, Martin; Klapper, Wolfram; Ott, German und Rosenwald, Andreas
(2015):
The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cells.
In: Haematologica, Bd. 100, Nr. 11, e458-61
Delfau-Larue, M. H.; Klapper, Wolfram; Berger, F.; Jardin, F.; Briere, J.; Salles, G.; Casasnovas, O.; Feugier, P.; Haioun, C.; Ribrag, Vincent; Thieblemont, C.; Unterhalt, Michael; Dreyling, Martin; Macintyre, E.; Pott, Christiane; Hermine, Olivier und Hoster, Eva
(2015):
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.
In: Blood, Bd. 126, Nr. 5: S. 604-611
Cheminant, M.; Derrieux, C.; Touzart, A.; Schmit, S.; Grenier, A.; Trinquand, A.; Delfau-Larue, M. H.; Lhermitte, L.; Thieblemont, C.; Ribrag, Vincent; Cheze, S.; Sanhes, L.; Jardin, F.; Lefrere, F.; Delarue, R.; Hoster, Eva; Dreyling, Martin; Asnafi, V.; Hermine, Olivier und Macintyre, E.
(2015):
Minimal Residual Disease monitoring by 8-color flow cytometry in Mantle Cell Lymphoma: an EU-MCL and LYSA study.
In: Haematologica, Bd. 101, Nr. 3: S. 336-345
Hoster, Eva; Geisler, C. H.; Doorduijn, J.; van der Holt, B.; Walewski, J.; Bloehdorn, J.; Ribrag, Vincent; Salles, G.; Hallek, M.; Pott, Christiane; Szymczyk, Michal; Kolstad, A.; Laurell, A.; Raty, R.; Jerkeman, M.; Van’t Veer, M.; Kluin-Nelemans, J. C.; Klapper, Wolfram; Unterhalt, Michael; Dreyling, Martin und Hermine, Olivier
(2015):
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.
In: Leukemia, Bd. 30, Nr. 6: S. 1428-1430
Pastore, Friederike; Kling, Daniela; Hoster, Eva; Dufour, Annika; Konstandin, Nikola P.; Schneider, Stephanie; Sauerland, Maria C.; Berdel, Wolfgang E.; Buechner, Thomas; Woermann, Bernhard; Braess, Jan; Hiddemann, Wolfgang und Spiekermann, Karsten
(2014):
Long-term follow-up of cytogenetically normal CEBPA-mutated AML.
In: Journal of Hematology & Oncology
7:55
[PDF, 851kB]
Hubmann, Max; Köhnke, Thomas; Hoster, Eva; Schneider, Stephanie; Dufour, Annika; Zellmeier, Evelyn; Fiegl, Michael; Braess, Jan; Bohlander, Stefan K.; Subklewe, Marion; Sauerland, Maria-Cristina; Berdel, Wolfgang E.; Büchner, Thomas; Woermann, Bernhard; Hiddemann, Wolfgang und Spiekermann, Karsten
(2014):
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.
In: Haematologica, Bd. 99, Nr. 8: S. 1317-1325
[PDF, 838kB]
Metzner, B.; Müller, T. H.; Gebauer, W.; Casper, J.; Kraemer, D.; Rosien, B.; Schumann-Binarsch, S.; Thole, R.; Köhne, C. H.; Dreyling, Martin; Hoster, Eva und Pott, Christiane
(2013):
Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
In: Annals of Hematology, Bd. 93, Nr. 5: S. 803-810
Dreyling, Martin; Kluin-Nelemans, H. C.; Bea, Silvia; Klapper, Wolfram; Vogt, N.; Delfau-Larue, M. H.; Hutter, Grit; Cheah, C.; Chiappella, A.; Cortelazzo, Sergio; Pott, Christiane; Hess, G.; Visco, C.; Vitolo, U.; Klener, P.; Aurer, I.; Unterhalt, Michael; Ribrag, Vincent; Hoster, Eva und Hermine, Olivier
(2013):
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
In: Leukemia & Lymphoma, Bd. 54, Nr. 4: S. 699-707
Nickel, T.; Emslander, I.; Sisic, Z.; David, R.; Schmaderer, C.; Marx, N.; Schmidt-Trucksäss, A.; Hoster, Eva; Halle, M.; Weis, M. und Hanssen, H.
(2012):
Modulation of dendritic cells and toll-like receptors by marathon running.
In: European Journal of Applied Physiology, Bd. 112, Nr. 5: S. 1699-1708
Kuehlmeyer, K.; Racine, E.; Palmour, N.; Hoster, Eva; Borasio, G. D. und Jox, R. J.
(2012):
Diagnostic and ethical challenges in disorders of consciousness and locked-in syndrome: a survey of German neurologists.
In: Journal of Neurology, Bd. 259, Nr. 10: S. 2076-2089
Schneider, F.; Hoster, Eva; Schneider, S.; Dufour, A.; Benthaus, T.; Kakadia, P. M.; Bohlander, Stefan K.; Braess, J.; Heinecke, A.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Feuring-Buske, M.; Buske, C.; Creutzig, U.; Thiede, C.; Zwaan, M. C.; Heuvel-Eibrink, M. M. van den; Reinhardt, D.; Hiddemann, Wolfgang und Spiekermann, Karsten
(2012):
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
In: Annals of Hematology, Bd. 91, Nr. 1: S. 9-18
Schneider, F.; Hoster, Eva; Unterhalt, Michael; Schneider, S.; Dufour, A.; Benthaus, T.; Mellert, G.; Zellmeier, Evelyn; Kakadia, P. M.; Bohlander, Stefan K.; Feuring-Buske, M.; Buske, C.; Braess, J.; Heinecke, A.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Hiddemann, Wolfgang und Spiekermann, Karsten
(2012):
The FLT3ITD level has a high prognostic impact in NPM1 mutated, but not NPM1 unmutated AML with a normal karyotype.
In: Blood, Bd. 119, Nr. 19: S. 4383-4386
Dufour, A.; Schneider, F.; Hoster, Eva; Benthaus, T.; Ksienzyk, Bianka; Schneider, S.; Kakadia, P. M.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Braess, J.; Subklewe, M.; Hiddemann, Wolfgang; Bohlander, Stefan K. und Spiekermann, Karsten
(2012):
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
In: Annals of Hematology, Bd. 91, Nr. 7: S. 1051-1063
Kluin-Nelemans, H. C.; Hoster, Eva; Hermine, Olivier; Walewski, J.; Trneny, Marek; Geisler, C. H.; Stilgenbauer, S.; Thieblemont, C.; Vehling-Kaiser, U.; Doorduijn, J. K.; Coiffier, B.; Forstpointner, R.; Tilly, H.; Kanz, L.; Feugier, P.; Szymczyk, Michal; Hallek, M.; Kremers, S.; Lepeu, G.; Sanhes, L.; Zijlstra, J. M.; Bouabdallah, R.; Lugtenburg, P. J.; Macro, M.; Pfreundschuh, M.; Prochazka, V.; Di Raimondo, F.; Ribrag, Vincent; Uppenkamp, M.; Andre, M.; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael und Dreyling, Martin
(2012):
Treatment of older patients with mantle-cell lymphoma.
In: New England Journal of Medicine / NEJM, Bd. 367, Nr. 6: S. 520-531
Koch, K.; Hoster, Eva; Unterhalt, Michael; Ott, German; Rosenwald, Andreas; Hansmann, Martin-Leo; Engelhard, Marianne; Hiddemann, Wolfgang und Klapper, Wolfram
(2012):
The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease.
In: Human Pathology, Bd. 43, Nr. 12: S. 2274-2281
Greif, Philipp A.; Dufour, A.; Konstandin, Nikola P.; Ksienzyk, Bianka; Zellmeier, Evelyn; Tizazu, B.; Sturm, J.; Benthaus, T.; Herold, Tobias; Yaghmaie, M.; Dorge, P.; Hopfner, K. P.; Hauser, A.; Graf, A.; Krebs, S.; Blum, H.; Kakadia, P. M.; Schneider, S.; Hoster, Eva; Schneider, F.; Stanulla, M.; Braess, J.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Hiddemann, Wolfgang; Spiekermann, Karsten und Bohlander, Stefan K.
(2012):
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
In: Blood, Bd. 120, Nr. 2: S. 395-403
Nickel, Thomas; Hanssen, Henner; Emslander, Ingrid; Drexel, Verena; Hertel, Gernot; Schmidt-Trucksaess, Arno; Summo, Claudia; Sisic, Zeljka; Lambert, Marius; Hoster, Eva; Halle, Martin und Weis, Michael
(2011):
Immunomodulatory Effects of Aerobic Training in Obesity.
In: Mediators of Inflammation, Bd. 2011, 308965
[PDF, 1MB]
Nickel, T.; Bigdeli, A.; Ziegler, F. von; Wilbert-Lampen, U.; Lackermair, K.; Horster, S.; Hoster, Eva; Überfuhr, P.; Scheidt, W. von; Weis, M. und Kaczmarek, I.
(2011):
Coronary dilatation after heart transplantation.
In: Transplantation, Bd. 92, Nr. 6: S. 697-702
Nickel, T.; Hanssen, H.; Emslander, I.; Drexel, V.; Hertel, G.; Schmidt-Trucksäss, A.; Summo, C.; Sisic, Z.; Lambert, M.; Hoster, Eva; Halle, M. und Weis, M.
(2011):
Immunomodulatory effects of aerobic training in obesity.
In: Mediators of Inflammation, Bd. 2011: S. 308965
Nickel, T.; Hanssen, H.; Sisic, Z.; Pfeiler, S.; Summo, C.; Schmauss, D.; Hoster, Eva und Weis, M.
(2011):
Immunoregulatory effects of the flavonol quercetin in vitro and in vivo.
In: European Journal of Nutrition, Bd. 50, Nr. 3: S. 163-172
Dreyling, Martin; Kluin-Nelemans, H. C.; Bea, Silvia; Hartmann, Elena; Salaverria, Itziar; Hutter, Grit; Perez-Galan, P.; Roue, G.; Pott, Christiane; Le Gouill, Steven; Cortelazzo, Sergio; Rule, S.; Hess, G.; Zaja, F.; Vitolo, U.; Szymczyk, Michal; Walewski, J.; Ribrag, Vincent; Unterhalt, Michael; Hermine, Olivier und Hoster, Eva
(2011):
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.
In: Leukemia & Lymphoma, Bd. 52, Nr. 12: S. 2226-2236
Hoster, Eva
(2011):
Prognostic relevance of clinical risk factors in mantle cell lymphoma.
In: Seminars in Hematology, Bd. 48, Nr. 3: S. 185-188
Jin, M. K.; Hoster, Eva; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang und Klapper, Wolfram
(2011):
Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.
In: Histopathology, Bd. 58, Nr. 4: S. 586-592
Hauke, D.; Reiter-Theil, S.; Hoster, Eva; Hiddemann, Wolfgang und Winkler, E. C.
(2011):
The role of relatives in decisions concerning life-prolonging treatment in patients with end -stage malignant disorders: informants, advocates or surrogate decision-makers?
In: Annals of Oncology, Bd. 22, Nr. 12: S. 2667-2674
Pott, Christiane; Hoster, Eva; Delfau-Larue, M. H.; Beldjord, K.; Böttcher, S.; Asnafi, V.; Plonquet, A.; Siebert, R.; Callet-Bauchu, E.; Andersen, N.; van Dongen, J. J.; Klapper, Wolfram; Berger, F.; Ribrag, Vincent; van Hoof, A. L.; Trneny, Marek; Walewski, J.; Dreger, P.; Unterhalt, Michael; Hiddemann, Wolfgang; Kneba, M.; Kluin-Nelemans, H. C.; Hermine, Olivier; Macintyre, E. und Dreyling, Martin
(2010):
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.
In: Blood, Bd. 115, Nr. 16: S. 3215-3223
Schroepf, S.; Kappler, R.; Brand, S.; Prell, C.; Lohse, P.; Glas, J.; Hoster, Eva; Helmbrecht, J.; Ballauff, A.; Berger, M.; Schweinitz, D. von; Koletzko, Sibylle und Lacher, M.
(2010):
Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
In: Inflammatory Bowel Diseases, Bd. 16, Nr. 11: S. 1882-1890
Dufour, A.; Schneider, F.; Metzeler, Klaus H.; Hoster, Eva; Schneider, S.; Zellmeier, Evelyn; Benthaus, T.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Braess, J.; Hiddemann, Wolfgang; Bohlander, Stefan K. und Spiekermann, Karsten
(2010):
Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.
In: Journal of Clinical Oncology, Bd. 28, Nr. 4: S. 570-577
Dreyling, Martin; Hoster, Eva; Bea, Silvia; Hartmann, Elena; Horn, Heike; Hutter, Grit; Salaverria, Itziar; Pott, Christiane; Trneny, Marek; Le Gouill, Steven; Cortelazzo, Sergio; Szymczyk, Michal; Jurczak, Wojciech; Shpilberg, Ofer; Ribrag, Vincent und Hermine, Olivier
(2010):
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.
In: Leukemia & Lymphoma, Bd. 51, Nr. 9: S. 1612-1622
Thoene, S.; Rawat, V. P.; Heilmeier, B.; Hoster, Eva; Metzeler, Klaus H.; Herold, Tobias; Hiddemann, Wolfgang; Gökbuget, Nicola; Hoelzer, D.; Bohlander, Stefan K.; Feuring-Buske, M. und Buske, C.
(2009):
The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia.
In: Leukemia, Bd. 23, Nr. 4: S. 649-655
Schneider, F.; Hoster, Eva; Unterhalt, Michael; Schneider, S.; Dufour, A.; Benthaus, T.; Mellert, G.; Zellmeier, Evelyn; Bohlander, Stefan K.; Feuring-Buske, M.; Buske, C.; Braess, J.; Fritsch, S.; Heinecke, A.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Hiddemann, Wolfgang und Spiekermann, Karsten
(2009):
NPM1, but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high risk myelodysplastic syndrome (MDS).
In: Blood, Bd. 113, Nr. 21: S. 5250-5253
Buske, C.; Hoster, Eva; Dreyling, Martin; Eimermacher, H.; Wandt, H.; Metzner, B.; Fuchs, R.; Bittenbring, J.; Wörmann, Bernhard; Hohloch, K.; Hess, G.; Ludwig, W. D.; Schimke, J.; Schmitz, S.; Kneba, M.; Reiser, M.; Graeven, U.; Klapper, Wolfram; Unterhalt, Michael und Hiddemann, Wolfgang
(2009):
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).
In: Leukemia, Bd. 23, Nr. 1: S. 153-161
Klapper, Wolfram; Hoster, Eva; Determann, Olaf; Oschlies, Ilske; Laak, Jeroen van der; Berger, F.; Bernd, Heinz Wolfram; Cabeçadas, José; Campo, Elias; Cogliatti, Sergio; Hansmann, Martin-Leo; Kluin, Philip M.; Kodet, Roman; Krivolapov, Yuri A.; Loddenkemper, Christoph; Stein, H.; Moeller, P.; Barth, Thomas E. F.; Mueller-Hermelink, K.; Rosenwald, Andreas; Pileri, S.; Ralfkiaer, E.; Rymkiewicz, G.; Krieken, Johan H. van; Wacker, Hans Heinrich; Unterhalt, Michael; Hiddemann, Wolfgang und Dreyling, Martin
(2009):
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network.
In: Journal of Hematopathology, Bd. 2, Nr. 2: S. 103-111
Herrmann, Annina; Hoster, Eva; Zwingers, T.; Brittinger, G.; Engelhard, Marianne; Meusers, P.; Reiser, M.; Forstpointner, R.; Metzner, B.; Peter, N.; Wörmann, Bernhard; Trümper, L.; Pfreundschuh, M.; Einsele, H.; Hiddemann, Wolfgang; Unterhalt, Michael und Dreyling, Martin
(2009):
Improvement of overall survival in advanced stage mantle cell lymphoma.
In: Journal of Clinical Oncology, Bd. 27, Nr. 4: S. 511-518
Determann, Olaf; Hoster, Eva; Ott, German; Wolfram-Bernd, H.; Loddenkemper, Christoph; Hansmann, Martin-Leo; Barth, Thomas E. F.; Unterhalt, Michael; Hiddemann, Wolfgang; Dreyling, Martin und Klapper, Wolfram
(2008):
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.
In: Blood, Bd. 111, Nr. 4: S. 2385-2387
Böttcher, S.; Ritgen, M.; Buske, S.; Gesk, S.; Klapper, Wolfram; Hoster, Eva; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin; Siebert, R.; Kneba, M. und Pott, Christiane
(2008):
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
In: Haematologica, Bd. 93, Nr. 4: S. 551-559
Hoster, Eva; Dreyling, Martin; Klapper, Wolfram; Gisselbrecht, C.; van Hoof, A.; Kluin-Nelemans, H. C.; Pfreundschuh, M.; Reiser, M.; Metzner, B.; Einsele, H.; Peter, N.; Jung, W.; Wörmann, Bernhard; Ludwig, W. D.; Dührsen, U.; Eimermacher, H.; Wandt, H.; Hasford, Joerg; Hiddemann, Wolfgang und Unterhalt, Michael
(2008):
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma, Erratum.
In: Blood, Bd. 111, Nr. 2: S. 558-565
Hoster, Eva; Dreyling, Martin und Unterhalt, Michael
(2008):
Response: Statistical power and validation of the MIPI.
In: Blood, Bd. 112, Nr. 6: S. 2583-2584
Hartmann, Elena; Fernàndez, V.; Moreno, V.; Valls, J.; Hernández, L.; Bosch, F.; Abrisqueta, P.; Klapper, Wolfram; Dreyling, Martin; Hoster, Eva; Müller-Hermelink, H. K.; Ott, German; Rosenwald, Andreas und Campo, Elias
(2008):
Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue.
In: Journal of Clinical Oncology, Bd. 26, Nr. 30: S. 4966-4972
Nickenig, C.; Dreyling, Martin; Hoster, Eva; Ludwig, W. D.; Dörken, B.; Freund, M.; Huber, C.; Ganser, A.; Trümper, L.; Forstpointner, R.; Unterhalt, Michael und Hiddemann, Wolfgang
(2007):
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas: Results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
In: Annals of Oncology, Bd. 18, Nr. 1: S. 136-142
Krauss-Etschmann, S.; Shadid, R.; Campoy, C.; Hoster, Eva; Demmelmair, H.; Jimenez, M.; Gil, Arthur; Rivero, M.; Veszpremi, B.; Decsi, T. und Koletzko, Berthold
(2007):
Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial.
In: American Journal of Clinical Nutrition, Bd. 85, Nr. 5: S. 1392-1400
Klapper, Wolfram; Hoster, Eva; Rolver, L.; Schrader, C.; Janssen, D.; Tiemann, M.; Bernd, Heinz Wolfram; Determann, Olaf; Hansmann, Martin-Leo; Möller, P.; Feller, A.; Stein, H.; Wacker, Hans Heinrich; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang und Ott, German
(2007):
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
In: Journal of Clinical Oncology, Bd. 25, Nr. 22: S. 3330-3336
Nickenig, C.; Dreyling, Martin; Hoster, Eva; Pfreundschuh, M.; Trumper, L.; Reiser, M.; Wandt, H.; Lengfelder, E.; Unterhalt, Michael und Hiddemann, Wolfgang
(2006):
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
In: Cancer, Bd. 107, Nr. 5: S. 1014-1022
Buske, C.; Hoster, Eva; Dreyling, Martin; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2006):
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vinc.
In: Blood, Bd. 108, Nr. 5: S. 1504-1508
Kaml, M.; Weiskirchner, I.; Keller, M.; Luft, T.; Hoster, Eva; Hasford, Joerg; Young, L.; Bartlett, B.; Neuner, C.; Fischer, K. H.; Neuman, B.; Würzner, R. und Grubeck-Loebenstein, B.
(2006):
Booster vaccination in the elderly: Their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers.
In: Vaccine, Bd. 24, Nr. 47-48: S. 6808-6811
Lenz, G.; Dreyling, Martin; Hoster, Eva; Wörmann, Bernhard; Dührsen, U.; Metzner, B.; Eimermacher, H.; Neubauer, A.; Wandt, H.; Steinhauer, H.; Martin, S.; Heidemann, E.; Aldaoud, A.; Parwaresch, R.; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2005):
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
In: Journal of Clinical Oncology, Bd. 23, Nr. 23: S. 1984-1992
Dreyling, Martin; Lenz, G.; Hoster, Eva; Van-Hoof, A.; Gisselbrecht, C.; Schmits, R.; Metzner, B.; Truemper, L.; Reiser, M.; Steinhauer, H.; Boiron, J. M.; Boogaerts, M. A.; Aldaoud, A.; Silingardi, V.; Kluin-Nelemans, H. C.; Hasford, Joerg; Parwaresch, R.; Unterhalt, Michael und Hiddemann, Wolfgang
(2005):
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.
In: Blood, Bd. 105, Nr. 7: S. 2677-2684